<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Evoke Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Evoke Pharma, Inc.

    Evoke Pharma, Inc. (NASDAQ: EVOK) is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) diseases. The Company was established by experienced specialty pharmaceutical executives with a successful track record of acquiring, developing, registering, and marketing pharmaceutical products in the US. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $69,400,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Gonyer, R.Ph.
    • FOUNDED
      2007
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused, biopharmaceutical...

    Neurocrine Biosciences (Nasdaq: NBIX) is a neur...

    Filing Type:    PU
    Insmed, Inc.

    Insmed, Inc.

    At Insmed we are on a mission to transform the lives of patients battling serious ...

    At Insmed we are on a mission to transform the ...

    Filing Type:    PU
    Evogene Ltd.

    Evogene Ltd.

    Evogene (NASDAQ, TASE: EVGN) is a leading biotechnology company developing novel p...

    Evogene (NASDAQ, TASE: EVGN) is a leading biote...

    Filing Type:    PU
    Phormed Inc

    Phormed Inc

    PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills Cal...

    PhorMed is a clinical stage biopharmaceutical c...

    Amount Raised:    $128,700.00
    Fundraising Status:    EC
    Filing Type:    CF
    Outlook Therapeutics, Inc.

    Outlook Therapeutics, Inc.

    Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on...

    Outlook Therapeutics is a late clinical-stage b...

    Filing Type:    PU
    Oramed Pharmaceuticals Inc.

    Oramed Pharmaceuticals Inc.

    Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a...

    Oramed Pharmaceuticals (NASDAQ: ORMP) was estab...

    Filing Type:    PU
    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics, Inc.

    Protagonist Therapeutics is a clinical stage biopharmaceutical company that utiliz...

    Protagonist Therapeutics is a clinical stage bi...

    Filing Type:    PU
    Redhill Biopharma Ltd.

    Redhill Biopharma Ltd.

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a special...

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv...

    Filing Type:    PU
    Novan, Inc.

    Novan, Inc.

    Novan, Inc. is a clinical development-stage biotechnology company focused on lever...

    Novan, Inc. is a clinical development-stage bio...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.